A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys
Phase 2
Completed
- Conditions
- Primary Insomnia
- Interventions
- Device: Microcurrent
- Registration Number
- NCT00520832
- Lead Sponsor
- Logan College of Chiropractic
- Brief Summary
Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia.
The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Student, Faculty or Staff
- Age 18 - 40
- Symptoms of primary insomnia
Exclusion Criteria
- No implanted electric devices
- No local infection, injury or malignancy
- No history of seizure or other neurological disorders
- No current use of prescription or other substances that could effect sleep quality or quantity
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MC-E Microcurrent 20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days. MC-P Microcurrent Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.
- Primary Outcome Measures
Name Time Method Pittsburgh Sleep Quality Index (PSQI) Epworth Sleepiness Scale Insomnia Severity Index
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Logan College of Chiropractic
🇺🇸Chesterfield, Missouri, United States